September 22, 2020
“Intellia Therapeutics (NTLA)… Looking at the consensus breakdown, 3 Buys and 2 Holds have been published in the last three months. Therefore, NTLA gets a Moderate Buy consensus rating. Based on the $37.13 average price target, shares could rise 67%… Continue Reading…
Recent Comments